Search Results - "Waddell, Tom Samuel"

Immunomodulatory switch maintenance therapy in metastatic colorectal carcinoma: The phase III IMPALA study by Cunningham, David, Scheithauer, Werner, Zurlo, Alfredo, Salazar, Ramon, Ducreux, Michel, Waddell, Tom Samuel, Tournigand, Christophe, Sobrero, Alberto F., Van Cutsem, Eric, Arnold, Dirk

“…Abstract only TPS785 Background: The Toll-like receptor 9 agonist MGN1703 was compared to placebo in 59 metastatic CRC (mCRC) patients with disease control…”
Get full text

Trends in resected oesophageal and gastric adenocarcinoma (OGA) outcomes: Royal Marsden (RM) experience 2001-2010 by Fontana, Elisa, Smyth, Elizabeth Catherine, Cunningham, David, Rao, Sheela, Watkins, David J., Allum, William H., Thompson, Jeremy, Waddell, Tom Samuel, Peckitt, Clare, Chau, Ian, Starling, Naureen

“…Abstract only 169 Background: OGA is a lethal cancer globally. Overall survival (OS) has improved in the last decade, potentially due to stage migration and…”
Get full text

IMPALA, a randomized phase III study in patients with metastatic colorectal carcinoma: Immunomodulatory maintenance therapy with TLR-9 agonist MGN1703 by Cunningham, David, Zurlo, Alfredo, Salazar, Ramon, Ducreux, Michel, Waddell, Tom Samuel, Stein, Alexander, Tournigand, Christophe, Scheithauer, Werner, Sobrero, Alberto F., Van Cutsem, Eric, Arnold, Dirk

“…Abstract only TPS791 Background: The potent TLR-9 agonist MGN1703, a synthetic DNA-based immunomodulator, was compared to placebo in metastatic colorectal…”
Get full text

Formulating a surveillance strategy following surgery for oesophagogastric cancer by Moorcraft, Sing Yu, Fontana, Elisa, Cunningham, David, Peckitt, Clare, Waddell, Tom Samuel, Smyth, Elizabeth Catherine, Allum, William H., Thompson, Jeremy, Rao, Sheela, Watkins, David, Starling, Naureen, Chau, Ian

“…Abstract only 153 Background: Oesophagogastric adenocarcinoma (OGA) has a poor prognosis, even for patients (pts) with operable disease. We conducted a…”
Get full text

Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma by Waddell, Tom Samuel, Chau, Ian, Peckitt, Clare, Gonzalez, David, Wotherspoon, Andrew, Patel, Bijal, Middleton, Gary William, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y., Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

“…Abstract only…”
Get full text

Prognostication in esophagogastric adenocarcinoma (OGA): Factors influencing overall survival (OS) in REAL3 by Waddell, Tom Samuel, Chau, Ian, Peckitt, Clare, Patel, Bijal, Gonzalez de Castro, David, Wotherspoon, Andrew, Middleton, Gary William, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y., Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

“…Abstract only 91 Background: The REAL3 trial evaluated the addition of panitumumab (P) to epirubicin, oxaliplatin and capecitabine (EOC) in advanced OGA. We…”
Get full text

A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3) by Waddell, Tom Samuel, Chau, Ian, Barbachano, Yolanda, Gonzalez de Castro, David, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary William, Wadsley, Jonathan, Ferry, David Raymond, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y, Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

“…Abstract only LBA4000 Background: EGFR overexpression occurs in 27-50% of esophagogastric adenocarcinomas (OGA), and correlates with poor prognosis. The REAL3…”
Get full text

A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3) by Waddell, Tom Samuel, Chau, Ian, Barbachano, Yolanda, Gonzalez de Castro, David, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary William, Wadsley, Jonathan, Ferry, David Raymond, Mansoor, Wasat, Crosby, Tom David Lewis, Coxon, Fareeda Y, Smith, David, Waters, Justin S., Iveson, Timothy, Falk, Stephen, Slater, Sarah, Okines, Alicia Frances Clare, Cunningham, David

“…Abstract only LBA4000 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Saturday, June 2, 2012, and in the…”
Get full text